南方医科大学学报
南方醫科大學學報
남방의과대학학보
JOURNAL OF SOUTHERN MEDICAL UNIVERSITY
2014年
2期
169-173
,共5页
杨军%郭睿%康安静%陈晓黎%苏宝山%黄小钟%靳耀锋%李宗芳
楊軍%郭睿%康安靜%陳曉黎%囌寶山%黃小鐘%靳耀鋒%李宗芳
양군%곽예%강안정%진효려%소보산%황소종%근요봉%리종방
结直肠癌%组织学分型%组织学分级-评分%分期
結直腸癌%組織學分型%組織學分級-評分%分期
결직장암%조직학분형%조직학분급-평분%분기
colorectal cancer%histological typing%histological grading-scale%staging
目的:提出一种新型结直肠癌组织学分型、分级-评分方案,为结直肠癌的生物学行为和预后判断提供评估指标。方法根据结直肠癌高度异质性的组织学特征、参照WHO分型方案和目前对结直肠癌组织学分型、分化程度与生物学行为相关性的研究成果,设计新型结直肠癌组织学分型、分级-评分方案:(1)将结直肠癌分为不同组织学类型并予以评分:④非黏液性腺癌(管状腺癌、筛状粉刺型腺癌、髓样癌、锯齿状腺癌、微乳头状癌等,1~3分);④黏液性腺癌(黏液腺癌、印戒细胞癌,评3~4分);④鳞癌(1~3分);④神经内分泌肿瘤(神经内分泌瘤、神经内分泌癌,1~4分);④特殊类型结直肠癌(透明细胞癌、梭形细胞癌等,4分);④未分化癌(5分);(2)病理诊断书写格式:按照组织学结构主次顺序诊断,如***癌伴***癌;(3)计分方法:将结直肠癌组织中的不同组织类型的分级-评分累计作为结直肠癌的总评分,单一结构组成的结直肠癌其分值乘以2获得最终得分。并采用这一方案对666例进展期结直肠癌患者病理标本进行组织学分型、分级-评分,分析其与TNM分期和淋巴结癌转移之间的相关性。结果结直肠癌组织学分级-评分与结直肠癌的TNM分期和是否伴有淋巴结癌转移关系密切,结直肠癌组织学分级-评分随着结直肠癌的TNM分期和淋巴结癌转移而升高,并具显著统计学意义(P<0.05)。结论该分级-评分方案能够客观评价结直肠癌的生物学行为和侵袭转移能力,有可能成为一个评价结直肠癌生物学行为及预后预测的具有重要价值的新客观指标,但仍有必要经过前瞻性多中心、大规模临床研究对该新型结直肠癌组织学分型、分级-评分方案进行持续修订和更新。
目的:提齣一種新型結直腸癌組織學分型、分級-評分方案,為結直腸癌的生物學行為和預後判斷提供評估指標。方法根據結直腸癌高度異質性的組織學特徵、參照WHO分型方案和目前對結直腸癌組織學分型、分化程度與生物學行為相關性的研究成果,設計新型結直腸癌組織學分型、分級-評分方案:(1)將結直腸癌分為不同組織學類型併予以評分:④非黏液性腺癌(管狀腺癌、篩狀粉刺型腺癌、髓樣癌、鋸齒狀腺癌、微乳頭狀癌等,1~3分);④黏液性腺癌(黏液腺癌、印戒細胞癌,評3~4分);④鱗癌(1~3分);④神經內分泌腫瘤(神經內分泌瘤、神經內分泌癌,1~4分);④特殊類型結直腸癌(透明細胞癌、梭形細胞癌等,4分);④未分化癌(5分);(2)病理診斷書寫格式:按照組織學結構主次順序診斷,如***癌伴***癌;(3)計分方法:將結直腸癌組織中的不同組織類型的分級-評分纍計作為結直腸癌的總評分,單一結構組成的結直腸癌其分值乘以2穫得最終得分。併採用這一方案對666例進展期結直腸癌患者病理標本進行組織學分型、分級-評分,分析其與TNM分期和淋巴結癌轉移之間的相關性。結果結直腸癌組織學分級-評分與結直腸癌的TNM分期和是否伴有淋巴結癌轉移關繫密切,結直腸癌組織學分級-評分隨著結直腸癌的TNM分期和淋巴結癌轉移而升高,併具顯著統計學意義(P<0.05)。結論該分級-評分方案能夠客觀評價結直腸癌的生物學行為和侵襲轉移能力,有可能成為一箇評價結直腸癌生物學行為及預後預測的具有重要價值的新客觀指標,但仍有必要經過前瞻性多中心、大規模臨床研究對該新型結直腸癌組織學分型、分級-評分方案進行持續脩訂和更新。
목적:제출일충신형결직장암조직학분형、분급-평분방안,위결직장암적생물학행위화예후판단제공평고지표。방법근거결직장암고도이질성적조직학특정、삼조WHO분형방안화목전대결직장암조직학분형、분화정도여생물학행위상관성적연구성과,설계신형결직장암조직학분형、분급-평분방안:(1)장결직장암분위불동조직학류형병여이평분:④비점액성선암(관상선암、사상분자형선암、수양암、거치상선암、미유두상암등,1~3분);④점액성선암(점액선암、인계세포암,평3~4분);④린암(1~3분);④신경내분비종류(신경내분비류、신경내분비암,1~4분);④특수류형결직장암(투명세포암、사형세포암등,4분);④미분화암(5분);(2)병리진단서사격식:안조조직학결구주차순서진단,여***암반***암;(3)계분방법:장결직장암조직중적불동조직류형적분급-평분루계작위결직장암적총평분,단일결구조성적결직장암기분치승이2획득최종득분。병채용저일방안대666례진전기결직장암환자병리표본진행조직학분형、분급-평분,분석기여TNM분기화림파결암전이지간적상관성。결과결직장암조직학분급-평분여결직장암적TNM분기화시부반유림파결암전이관계밀절,결직장암조직학분급-평분수착결직장암적TNM분기화림파결암전이이승고,병구현저통계학의의(P<0.05)。결론해분급-평분방안능구객관평개결직장암적생물학행위화침습전이능력,유가능성위일개평개결직장암생물학행위급예후예측적구유중요개치적신객관지표,단잉유필요경과전첨성다중심、대규모림상연구대해신형결직장암조직학분형、분급-평분방안진행지속수정화경신。
Objective To formulate a novel histological typing and grading-rated system for colorectal cancer (CRC) for evaluating the biological behavior of CRC and prognosis. Methods According to the highly heterogeneous histological features, WHO classification and histological differentiation criteria, and other biological behavior parameters of CRC, a novel histological typing and grading-scale system for CRC was designed. The histological typing and corresponding grading-scale of CRC was defined as the following:(1) No mucin-producing adenocarcinoma, including tubular adenocarcinoma, sieve-like acne adenocarcinoma, medullary carcinoma, serrated adenocarcinoma and micropapillary carcinoma, etc. (1-3 points); (2) Mucin-producing adenocarcinoma, including mucinous adenocarcinoma and signet ring cell carcinoma (3-4 points); (3) Squamous cell carcinoma (1- 3 points); (4) Neuroendocrine tumors, including neuroendocrine tumors, neuroendocrine carcinoma (1-4 points);(5) The special type of CRC, including clear cell carcinoma, spindle cell carcinoma, etc. (4-points);(6) Undifferentiated carcinoma (5 points). The pathology report form was formated based on the major histological type with the secondary histological type. The final total score of CRC was defined as the sum of the corresponding grading scores for different histological types. The total score of a single-structure CRC was defined as the corresponding grading score multiplied by 2. A total of 666 patients with advanced CRC were pathologically reviewed and analyzed to assess the correlation of the histological typing and grading scores with TNM staging and lymph node metastasis. Results The results showed a significant correlation of the histological grading-scale and TNM staging and lymph node metastasis (P<0.05). The scores of CRC histological grading-scale increased synchronously with the TNM staging and lymph node metastasis rate. Conclusion The novel histological grading system allows objective evaluation of the biological behaviors and prognosis of CRC for determining individualized postoperative treatment. This system still needs further revision and updates based on evidence from prospective, multi-centered, large-scale trials.